Read More>>
Drug firm WockhardtNSE 2.62 % has set up its first facility in the Middle East in Dubai for manufacture of new chemical entities (NCEs) to cater to global markets. The facility is spread over 10,000 sq meters, self-sufficient for handling warehousing, manufacturing operations, product testing and product stability, Wockhardt said in a statement.
"With the new facility in the Middle East, we aim to focus on our commitment to developing NCEs to fight the health issues," “Wockhardt Founder Chairman Habil Khorakiwala said